BLOG

Thursday, November 1, 2018

Roche ties up with Wellthy Therapeutics for AI-based diabetes management

Drug firm Roche Wednesday said it has partnered with Wellthy Therapeutics to offer users of the Accu-Chek Active system an artificial intelligence-based digital diabetes coaching solution. The joint offering of the two companies will encompass Accu-Chek Active blood glucose meter and the Wellthy Care app to the new users. The bundle is being launched in the south as well western parts of the country. "With Wellthy's digital diabetes health coach, new Accu-Chek Active users can log blood glucose readings into the app to receive 24/7 guidance on understanding and managing their diabetes better. We firmly believe that this joint offering will help in improving the quality of life for Indians living with type 2 diabetes," Roche Diabetes Care India Ad-Interim General Manager Rahul Kedia said. Wellthy Therapeutics Co-Founder & CEO Abhishek Shah said the partnership marks an important first step, in a larger shared vision to make a meaningful difference to the lives of millions of people

from Companies https://ift.tt/2Rudmnt
via IFTTT

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...